Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line

Bioorganic & Medicinal Chemistry Letters
2017.0

Abstract

Taking into account that multidrug resistance (MDR) is the main cause for chemotherapeutic failure in cancer treatment and as a continuation of our efforts to overcome this problem we report the evaluation of one cyclic selenoanhydride (1) and ten selenoesters (2-11) in MDR human colon adenocarcinoma Colo 320 cell line. The most potent derivatives (1, 9-11) inhibited the ABCB1 efflux pump much stronger than the reference compound verapamil. Particularly, the best one (9) was 4-fold more potent than verapamil at a 10-fold lower concentration. Furthermore, the evaluated derivatives exerted a potent and selective cytotoxic activity. In addition, they were strong apoptosis inducers as the four derivatives triggered apoptotic events in a 64-72% of the examined MDR Colo 320 human adenocarcinoma cells.

Knowledge Graph

Similar Paper

Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line
Bioorganic & Medicinal Chemistry Letters 2017.0
Identification of selenocompounds with promising properties to reverse cancer multidrug resistance
Bioorganic & Medicinal Chemistry Letters 2016.0
Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells
Bioorganic & Medicinal Chemistry 2010.0
Novel Multidrug Resistance Reversal Agents
Journal of Medicinal Chemistry 1999.0
Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells
Journal of Natural Products 2015.0
Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines
European Journal of Medicinal Chemistry 2016.0
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold
European Journal of Medicinal Chemistry 2015.0
Synthesis and biological evaluation of taxinine analogues as orally active multidrug resistance reversal agents in cancer
Bioorganic & Medicinal Chemistry Letters 2004.0
Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance
European Journal of Medicinal Chemistry 2018.0
N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins
Bioorganic & Medicinal Chemistry Letters 2020.0